Sinopharm Group Co Ltd
HKEX:1099
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sinopharm Group Co Ltd
HKEX:1099
|
CN |
|
F
|
F5 Inc
F:FFV
|
US |
|
E
|
Eli Lilly and Co
SWB:LLY
|
US |
|
Ventas Inc
NYSE:VTR
|
US |
|
Taiga Building Products Ltd
TSX:TBL
|
CA |
|
Klepierre SA
F:KPR
|
FR |
|
Amplitude Energy Ltd
F:CDP0
|
AU |
|
Warner Bros Discovery Inc
NASDAQ:WBD
|
US |
|
M
|
Mirvac Group
OTC:MRVGF
|
AU |
|
General Dynamics Corp
NYSE:GD
|
US |
Intrinsic Value
Is Sinopharm Group Co Ltd undervalued or overvalued?
See the intrinsic value estimate for Sinopharm Group Co Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Sinopharm Group Does
Sinopharm Group is one of China’s biggest drug distributors and pharmacy operators. It buys medicines, vaccines, medical devices, and healthcare products from manufacturers, then moves them through its own wholesale and retail network to hospitals, clinics, pharmacies, and other healthcare buyers. It also sells over-the-counter products and runs pharmacy stores under its own retail banners.
- Headquarters
- China CN
- Employees
- 94 910
- IPO date
- Sep 23, 2009
Sinopharm Group has no economic moat
Sinopharm Group Co Ltd lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis
Earnings Waterfall
Sinopharm Group Co Ltd
The intrinsic value for Sinopharm Group Co Ltd (1099) under the Base Case is hidden HKD.
Compared with the current market price of 16.34 HKD, the stock appears hidden.
